Medipol Oncology Department specializes in the treatment of cancer applying immunotherapy. It is innovative therapy which is still approved by FDA (Food and Drug Administration) for treatment of several cancer types. But in some cases (at the advanced cancer or when chemotherapy is ineffective) oncologists assign immunotherapy. It is based on injecting into a patient’s body special biologically active substance. The material detects malignant cells and stops their development. In several months these cells die.
The advantage of immunotherapy is that it has higher effectiveness and fewer side effects compared to chemotherapy.
accreditations:
Extended analysis of blood | $316.76 - $1267.04 |
MRI of one area | $1245.92 |